Sign in

You're signed outSign in or to get full access.

Jeffrey Monat

Chairman of the Board at Leafly Holdings, Inc. /DE
Board

About Jeffrey Monat

Independent director and current Chairman of the Board of Leafly Holdings, Inc. (Class III; term expires 2027), age 46, appointed March 25, 2024. He is deemed independent under Nasdaq rules and Rule 10A‑3 and serves as an audit committee financial expert; education includes a B.S. in Economics from The Wharton School (University of Pennsylvania). Core credentials span >20 years of institutional investing and cannabis industry experience since 2013 .

Past Roles

OrganizationRoleTenureCommittees/Impact
Merida Merger Corp. I (SPAC)DirectorAug 2019 – Feb 2022Predecessor to Leafly’s public listing via business combination; governance and transaction oversight
Sage Rock CapitalSenior Analyst2016 – 2018Event-driven investing
Seven Locks CapitalSenior Analyst2012 – 2016Long/short equity investing
FrontPoint RockbayInvestment professional2010 – 2012Event-driven hedge fund
Rockbay CapitalInvestment Analyst2003 – 2010Investment analysis
Goldman SachsM&A Advisory; Principal Strategies2000 – 2003M&A, valuation, corporate governance advisory; principal investing

External Roles

OrganizationRoleDatesNotes
Merida Capital HoldingsSenior Partner2018 – PresentPrivate equity firm; cannabis exposure since 2013
Lowell Farms Inc.Independent DirectorJan 2022 – PresentPublic cannabis company directorship
Friends Grow Friends Foundation, Inc.Treasurer & TrusteeOngoingNon-profit board role

Board Governance

  • Board leadership: Chairman of the Board; presides over meetings and leads independent oversight .
  • Independence: Two current independent directors (Monat, Nannetti); audit committee members satisfy Rule 10A‑3 and financial expert criteria .
  • Committees (current): Audit (Chair), Compensation (Member), Nominating & Corporate Governance (Chair). Majority of nominating committee independent; compensation committee composed of independent directors .
  • Attendance and engagement:
    • Board held 7 meetings in 2024; all directors attended the 2024 annual meeting .
    • 2023 Board and committee attendance was 100% by all directors; Audit Committee met 5 times in 2023 with 100% attendance .
    • Nominating & Corporate Governance met 5 times in 2024 with 100% attendance; Compensation met 4 times in 2024 with 100% attendance .
  • Executive sessions: Independent directors meet regularly in executive sessions without management .
CommitteeRole2024 Meetings2023 MeetingsAttendance (latest disclosed)
BoardChairman7 (2024) 100% in 2023
AuditChair5 (2023) 100% in 2023
CompensationMember4 (2024) 100% in 2024
Nominating & Corporate GovernanceChair5 (2024) 100% in 2024

Notable governance actions:

  • Transaction approval: The going‑private reverse split and “Transaction” were approved by the Board, including current independent directors Jeffrey Monat and Andres Nannetti; no special committee was formed and no external fairness opinion was obtained .

Fixed Compensation

Component (2024)Amount ($)Notes
Fees Earned or Paid in Cash81,593Reflects pro‑rated board chair and committee retainers after appointment on Mar 25, 2024 .

Director retainer schedule (non‑employee directors):

Retainer TypePre-Apr 1, 2024 ($)Post-Apr 1, 2024 ($)
Board Chair80,000 95,000
Board Member (non-chair)50,000 65,000
Audit Chair32,500 30,000
Compensation Chair22,500 20,000
Nominating Chair17,500 10,000
Audit Member22,500 20,000
Compensation Member14,500 12,500
Nominating Member12,500 7,500

Additional notes:

  • No individual meeting fees; travel expense reimbursements permitted .

Performance Compensation

Grant TypeGrant DateShares GrantedFair Value ($)Vest DatePerformance Metrics
RSU (Director annual grant)Jun 1, 20247,50010,950Jul 1, 2025Time‑based vesting; no performance metrics disclosed for director RSUs .

Other Directorships & Interlocks

Company/EntityRoleDatesInterlock/Exposure
Lowell Farms Inc.Independent DirectorJan 2022 – PresentExternal public cannabis company directorship
Merida Merger Corp. I (SPAC)DirectorAug 2019 – Feb 2022Historical linkage to Leafly’s business combination; related sponsor share and promissory note arrangements tied to the SPAC sponsor (Merida) .
Merida Capital HoldingsSenior Partner2018 – PresentPrivate equity investment role with cannabis focus; potential network interlocks in sector .
Leafly Board NetworkPeter Lee previously served at Merida and is now Leafly’s President/COO and director, indicating Merida network interlocks at the board level .

Expertise & Qualifications

  • Audit committee financial expert; meets Nasdaq financial literacy requirements .
  • Institutional investing, M&A, valuation, corporate governance; cannabis investing since 2013 .
  • Education: B.S. in Economics, The Wharton School (University of Pennsylvania) .

Equity Ownership

HolderTotal Beneficial Ownership (Shares)Ownership %RSUs (Unvested)Warrants (Exercisable Shares)Strike PricePledging/Hedging
Jeffrey Monat19,698 <1% (*) 7,500 scheduled to vest within 60 days of May 1, 2025 7,211 shares via 144,209 warrants $230 per share Company prohibits hedging/pledging absent pre‑approval; no pledging disclosed .

Ownership alignment context:

  • Directors and officers collectively held ~6.9% pre‑Transaction; anticipated to ~7.6–8.0% post‑Transaction depending on split ratio, indicating modest alignment increase from going‑private structure .

Governance Assessment

  • Strengths

    • Independent chair with dual committee chair roles (Audit; Nominating) and audit financial expertise—supports robust oversight of financial reporting and board composition .
    • High engagement: disclosed 100% attendance in 2023 for board/committees; 2024 committees met frequently (Comp: 4; Nom/Gov: 5) with 100% attendance .
    • Hedging/pledging restrictions enhance alignment and risk control .
  • Potential conflicts/RED FLAGS

    • Merida network interlocks: current chair is a Senior Partner at Merida Capital and ex‑director of Merida SPAC; Leafly director/President Peter Lee previously held executive roles at Merida; SPAC sponsor had related arrangements—raises perception risk on independence in strategic decisions .
    • Procedural safeguards in going‑private: Board (including independent directors) approved reverse split; no special committee or external fairness opinion was used—a governance concern in transactions affecting minority holders .
    • Ownership alignment: individual stake <1%—limited “skin‑in‑the‑game” despite leadership influence .
  • Director pay structure signals

    • April 2024 adjustments increased board retainers and streamlined committee fees; 2024 cash paid to Monat ($81,593) plus time‑based RSUs ($10,950 FV) suggest conventional director pay with limited performance‑linkage .
  • Shareholder engagement

    • Independent directors meet in executive session; all directors attended the 2024 annual meeting, indicating engagement .

Related-Party Exposure

  • Historical arrangements tied to Merida SPAC sponsor (forfeitures/escrow; non‑interest promissory notes)—context for interlocks; no current ongoing related‑party cash flows disclosed for Monat personally .

Director Compensation Mix

YearCash (Fees)Equity (RSUs FV)Meeting FeesNotes
2024$81,593 $10,950 None RSUs granted Jun 1, 2024; vest Jul 1, 2025

No options or PSUs disclosed for directors in 2024; equity awards are time‑based RSUs rather than performance‑conditioned .

Committee Assignments, Chair Roles, Expertise

CommitteeRoleExpertise/Notes
AuditChairAudit committee financial expert; Rule 10A‑3 independence
CompensationMemberCurrent composition of independent directors; 2024 committee met 4 times
Nominating & Corporate GovernanceChairMajority independent; 2024 committee met 5 times

Independence, Attendance, Engagement

  • Independence: Board has two independent directors; Monat meets Nasdaq independence and Rule 10A‑3 criteria .
  • Attendance: Board held 7 meetings in 2024; directors attended the 2024 annual meeting; 2023 board and committees saw 100% attendance .
  • Engagement: Independent executive sessions and active committee work .

Other Notes (Policies)

  • Hedging/pledging policy: Directors prohibited from hedging/pledging company securities without prior approval; margin accounts also restricted .

(*) Less than 1 percent .